info@ceoworld.biz
Monday, April 29, 2024
CEOWORLD magazine - Archive in Ron Cooper

Ron Cooper

Ron Cooper

Ron Cooper is the former President and CEO of Albireo Pharma and a current board member of Generation Bio. Albireo Pharma was a rare disease company focused on developing novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved in the US and Europe for a rare pediatric liver disease. The Company was acquired by Ipsen Pharmaceuticals in 2023.


Ron Cooper is an opinion columnist and Executive Council member at the CEOWORLD magazine. You can follow him on LinkedIn.
Ron Cooper
CEO Briefing

Making the Seemingly Impossible Possible…The Secret Behind Building a Trust Culture

Take this simple test:  What one word can help companies outperform their peers by up to 400%, increase employee motivation 260%, and reduce absenteeism by 41%? If your response is “trust,” congratulations!  A recent Deloitte study reinforced the power of trust in earning competitive advantage and long-term loyalty.  But knowing...